Potential plausible role of Wharton’s jelly mesenchymal stem cells for diabetic bone regeneration
Year: 2024
Type: article
Abstract: This letter addresses the review titled "Wharton's jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury". The review highlights the regenerative potential of Wharton's jelly mesenchymal stem cells (WJ-MSCs) and describes why WJ-MSCs will become one of the most probable stem cells for future regenerative medicine. The potential plausible role of WJ-MSCs for diabetic bone regeneration should be noticeable, which will provide a new strategy for improving bone regeneration under diabetic conditions.
Source: World Journal of Stem Cells
Authors: Sheng Zheng, Guan-Yu Hu, Jun-Hua Li, Yi-Kai Li
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4401866356
